Xilio Therapeutics (XLO) Short Interest Ratio & Short Volume → Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad) Free XLO Stock Alerts $0.92 -0.13 (-12.41%) (As of 05/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Xilio Therapeutics Short Interest DataCurrent Short Interest419,100 sharesPrevious Short Interest456,500 sharesChange Vs. Previous Month-8.19%Dollar Volume Sold Short$469,392.00Short Interest Ratio0.3 Days to CoverLast Record DateMay 15, 2024Outstanding Shares36,910,000 sharesFloat Size20,730,000 sharesShort Percent of Float2.02%Today's Trading Volume633,057 sharesAverage Trading Volume857,636 sharesToday's Volume Vs. Average74% Short Selling Xilio Therapeutics ? Sign up to receive the latest short interest report for Xilio Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartXLO Short Interest Over TimeXLO Days to Cover Over TimeXLO Percentage of Float Shorted Over Time Ad InvestorPlaceMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… Xilio Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/2024419,100 shares $469,392.00 -8.2%2.0%0.3 $1.12 4/30/2024456,500 shares $474,760.00 +20.3%5.2%0.4 $1.04 4/15/2024379,500 shares $478,170.00 +600.2%4.4%0.3 $1.26 3/31/202454,200 shares $58,536.00 -5.9%0.7%0 $1.08 3/15/202457,600 shares $39,456.00 +171.7%0.4%0.3 $0.69 2/29/202421,200 shares $15,030.80 -37.3%0.2%0.1 $0.71 Get the Latest News and Ratings for XLO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Xilio Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/202433,800 shares $19,854.12 +2,012.5%0.2%0.2 $0.59 1/31/20241,600 shares $1,040.00 -75.4%0.0%0 $0.65 1/15/20246,500 shares $4,831.45 +364.3%0.1%0 $0.74 12/31/20231,400 shares $770.00 -92.5%0.0%0 $0.55 12/15/202318,600 shares $13,206.00 -65.6%0.1%0.4 $0.71 11/30/202354,100 shares $51,395.00 +86.6%0.4%2.2 $0.95 11/15/202329,000 shares $38,860.00 +14.6%0.2%1.5 $1.34 10/31/202325,300 shares $54,395.00 -4.5%0.2%1.7 $2.15 10/15/202326,500 shares $46,375.00 +7.7%0.2%2.2 $1.75 9/30/202324,600 shares $51,906.00 +98.4%0.2%2.1 $2.11 9/15/202312,400 shares $29,264.00 -77.0%0.1%1.1 $2.36 8/31/202353,900 shares $154,693.00 -2.7%0.4%4 $2.87 8/15/202355,400 shares $151,242.00 -7.1%0.4%4.2 $2.73 7/31/202359,600 shares $170,456.00 -23.6%0.4%4.1 $2.86 7/15/202378,000 shares $206,700.00 -4.5%0.6%4.9 $2.65 6/30/202381,700 shares $214,054.00 -46.2%0.6%3.6 $2.62 6/15/2023151,800 shares $414,414.00 -21.4%1.2%6.5 $2.73 5/31/2023193,100 shares $588,955.00 -3.3%1.5%8.9 $3.05 5/15/2023199,600 shares $612,772.00 +1.0%1.7%7.6 $3.07 4/30/2023197,600 shares $652,080.00 -12.1%1.8%7 $3.30 4/15/2023224,700 shares $741,510.00 +25.7%2.0%4.3 $3.30 3/31/2023178,700 shares $566,479.00 +58.6%1.6%3.4 $3.17 3/15/2023112,700 shares $311,052.00 +160.9%1.0%2.2 $2.76 2/28/202343,200 shares $155,952.00 +77.1%0.4%0.9 $3.61 2/15/202324,400 shares $77,592.00 -62.6%0.3%0.5 $3.18 1/31/202365,200 shares $237,980.00 +239.6%0.7%1.3 $3.65 1/15/202319,200 shares $51,072.00 -31.4%0.2%0.5 $2.66 12/30/202228,000 shares $75,320.00 +1.8%0.3%1 $2.69 12/15/202227,500 shares $62,700.00 -0.7%0.3%0.9 $2.28 11/30/202227,700 shares $67,034.00 +12.2%0.3%0.3 $2.42 11/15/202224,700 shares $59,280.00 +34.2%0.3%0.3 $2.40 10/31/202218,400 shares $43,056.00 -41.4%0.2%0.2 $2.34 10/15/202231,400 shares $72,220.00 -34.0%0.3%0.3 $2.30 9/30/202247,600 shares $138,516.00 -15.3%0.5%0.4 $2.91Log Into Marc's $5,000 System Today (Ad)New Panic Could Sweep America Mark these words in 2024. Everyone's going to cash… Wall Street legend says: "A little-known vehicle outside of banks could double… triple… or even quadruple your life savings if you know where to find it right now." We urge you to move your cash into this vehicle in 2024. More here. 9/15/202256,200 shares $177,030.00 +72.4%0.6%0.4 $3.15 8/31/202232,600 shares $73,024.00 -45.4%0.3%0.3 $2.24 8/15/202259,700 shares $146,265.00 +114.8%0.6%0.5 $2.45 7/31/202227,800 shares $80,620.00 -48.1%0.3%0.2 $2.90 7/15/202253,600 shares $165,624.00 -31.9%0.5%0.5 $3.09 6/30/202278,700 shares $229,804.00 -65.4%0.8%0.7 $2.92 6/15/2022227,400 shares $518,472.00 -31.0%2.3%2.8 $2.28 5/31/2022329,400 shares $988,200.00 -3.1%3.3%5.8 $3.00 5/15/2022339,800 shares $1.15 million +4.2%3.4%8.7 $3.37 4/30/2022326,200 shares $1.15 million +47.0%3.3%9.5 $3.53 4/15/2022221,900 shares $1.34 million -8.0%2.3%6.7 $6.04 3/31/2022241,200 shares $1.71 million +1.9%2.6%8.8 $7.07 3/15/2022236,700 shares $1.66 million +3.4%2.5%6.4 $7.01 2/28/2022228,900 shares $2.70 million -3.6%2.5%2.7 $11.78 2/15/2022237,400 shares $3.45 million -4.8%2.6%2.5 $14.54 1/31/2022249,400 shares $3.39 million -14.9%2.6%2.3 $13.61 1/15/2022292,900 shares $4.25 million -26.9%3.0%2.3 $14.52 12/31/2021400,900 shares $6.41 million No ChangeN/A2.3 $16.00 XLO Short Interest - Frequently Asked Questions What is Xilio Therapeutics' current short interest? Short interest is the volume of Xilio Therapeutics shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 419,100 shares of XLO short. 2.02% of Xilio Therapeutics' shares are currently sold short. Learn More on Xilio Therapeutics' current short interest. What is a good short interest percentage for Xilio Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.02% of Xilio Therapeutics' floating shares are currently sold short. Is Xilio Therapeutics' short interest increasing or decreasing? Xilio Therapeutics saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 419,100 shares, a drop of 8.2% from the previous total of 456,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Xilio Therapeutics' float size? Xilio Therapeutics currently has issued a total of 36,910,000 shares. Some of Xilio Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Xilio Therapeutics currently has a public float of 20,730,000 shares. How does Xilio Therapeutics' short interest compare to its competitors? 2.02% of Xilio Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Xilio Therapeutics: Immuneering Co. (16.80%), NextCure, Inc. (0.43%), Aadi Bioscience, Inc. (5.54%), Gain Therapeutics, Inc. (0.60%), Ocuphire Pharma, Inc. (5.09%), Clene Inc. (0.16%), Acurx Pharmaceuticals, Inc. (4.43%), Daré Bioscience, Inc. (0.53%), BioLineRx Ltd. (0.27%), HCW Biologics Inc. (0.01%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Xilio Therapeutics stock? Short selling XLO is an investing strategy that aims to generate trading profit from Xilio Therapeutics as its price is falling. XLO shares are trading down $0.13 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Xilio Therapeutics? A short squeeze for Xilio Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of XLO, which in turn drives the price of the stock up even further. How often is Xilio Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including XLO, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Immuneering Short Squeeze NextCure Short Squeeze Aadi Bioscience Short Squeeze Gain Therapeutics Short Squeeze Ocuphire Pharma Short Squeeze Clene Short Squeeze Acurx Pharmaceuticals Short Squeeze Daré Bioscience Short Squeeze BioLineRx Short Squeeze HCW Biologics Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:XLO) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersWARNING about the death of the U.S. dollar…Colonial MetalsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsBitcoin’s Biggest Year YetParadigm PressThe #1 Crypto for AIWeiss RatingsDigitizing the $11T commodities sector with one tiny stockResource Stock DigestTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesElon’s New Device is About to Shock the WorldInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xilio Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.